PATH Form 4: Annual RSU Grant Boosts Director’s Stake to 3.16 M

Rhea-AI Filing Summary

UiPath (PATH) Form 4 filing: Director Philippe Botteri received an annual grant of 16,064 Restricted Stock Units (RSUs) on 26 Jun 2025 under the company’s non-employee director compensation policy. Each RSU converts into one Class A share when vested. The award vests on the earlier of the next annual meeting or the first anniversary of the grant date, provided the director remains in service.

The RSUs were issued at a price of $0.00, so no cash changed hands and no open-market transaction occurred. Following the grant, Botteri’s beneficial ownership rises to 3,160,889 Class A shares. No derivative securities or additional transactions were reported. The filing contains no other material corporate developments or financial metrics and is considered routine, with negligible dilution relative to UiPath’s total share count.

Insights

Securities Analyst

TL;DR: Routine RSU grant to director; minor size; neutral for valuation and sentiment.

This Form 4 documents a standard annual equity award—16,064 RSUs—to non-employee director Philippe Botteri. The award represents roughly 0.005% of UiPath’s ~320 M diluted share count, so dilution is immaterial. Because the grant is compensation-related and cost-free to the insider, it does not signal personal conviction through cash purchase, nor does it alter governance dynamics. Insider ownership rises modestly to 3.16 M shares (approximately 1.0% of shares outstanding), maintaining alignment with shareholders. Overall impact: neutral.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Botteri Philippe

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	16,064	$0.00	--

Holdings After Transaction: Class A Common Stock — 3,160,889 shares (Direct)

Footnotes (1)

1. This grant was made pursuant to the issuer's non-employee director compensation policy. Includes 16,064 Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of Issuer's Class A Common Stock upon settlement. Each Annual Director RSU vests on the earlier of the date of the following year's annual meeting (or the date immediately prior to the next annual meeting, if the non-employee director's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election), or the first anniversary of the date of grant, in each case subject to the director's continued service through such vesting date. Includes 1,238 shares of Class A common stock acquired by the Reporting Person in a distribution for no consideration on October 9, 2024, in accordance with the exemptions afforded by Rules 16a-9 and 16a-13 of the Securities Exchange Act of 1934, as amended.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Botteri Philippe

(Last) (First) (Middle)

C/O UIPATH, INC., ONE VANDERBILT AVENUE

(Street)

NEW YORK NY 10017

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UiPath, Inc. [ PATH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	06/26/2025		A(1)		16,064(2)	A	$0.00	3,160,889(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This grant was made pursuant to the issuer's non-employee director compensation policy.

2. Includes 16,064 Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of Issuer's Class A Common Stock upon settlement. Each Annual Director RSU vests on the earlier of the date of the following year's annual meeting (or the date immediately prior to the next annual meeting, if the non-employee director's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election), or the first anniversary of the date of grant, in each case subject to the director's continued service through such vesting date.

3. Includes 1,238 shares of Class A common stock acquired by the Reporting Person in a distribution for no consideration on October 9, 2024, in accordance with the exemptions afforded by Rules 16a-9 and 16a-13 of the Securities Exchange Act of 1934, as amended.

Remarks:

	/s/ Brad Brubaker, as Attorney-in-Fact	06/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many RSUs did UiPath director Philippe Botteri receive?

16,064 Restricted Stock Units were granted on 26 Jun 2025.

What is the vesting schedule for the 2025 director RSU grant at PATH?

The RSUs vest on the earlier of the next annual shareholder meeting or one year from the grant date, subject to continued service.

What is Botteri’s total UiPath share ownership after this transaction?

He beneficially owns 3,160,889 Class A shares following the grant.

Was any cash paid for the shares disclosed in this Form 4?

No. The RSUs were issued at $0.00; no open-market purchase occurred.

Is the transaction part of UiPath’s non-employee director compensation policy?

Yes. The filing states the grant was made pursuant to the company’s director compensation policy.